Omega-3 fatty acids as a psychotherapeutic agent for a pregnant schizophrenic patient

研究成果: 雜誌貢獻文章同行評審

29 引文 斯高帕斯(Scopus)

摘要

Because of the potential adverse events and teratogenesis of antipsychotic drugs, it is important to find a safe and effective treatment for pregnant women with severe mental illness. The membrane hypothesis of schizophrenia provides a rationale to treat symptoms of schizophrenia with omega-3 PUFAs. We report a 30-year-old married woman with chronic schizophrenia, who experienced an episode of acute exacerbation of psychotic symptoms during pregnancy. After entering into an open trial of omega-3 PUFAs monotherapy, she showed a dramatic improvement in both positive and negative symptoms of schizophrenia and a significant increase of omega-3 PUFA composition in erythrocyte membrane. There were no adverse effects in this treatment. Thus, omega-3 PUFAs could be both beneficial and therapeutic to pregnant schizophrenic women.
原文英語
頁(從 - 到)295-299
頁數5
期刊European Neuropsychopharmacology
11
發行號4
DOIs
出版狀態已發佈 - 2001

ASJC Scopus subject areas

  • 藥理
  • 神經內科
  • 神經病學(臨床)
  • 精神病學和心理健康
  • 生物精神病學
  • 藥學(醫學)

指紋

深入研究「Omega-3 fatty acids as a psychotherapeutic agent for a pregnant schizophrenic patient」主題。共同形成了獨特的指紋。

引用此